Skip to content

The effect of tacrolimus eye drop in treatment of herpetic corneal ulcer

Evaluation of topical tacrolimus eye drop 0.05% in treatment of non-necrotizing HSV stromal keratitis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016102429871N2
Enrollment
50
Registered
2016-11-17
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpetic non-necrotizing stormal keratitis. Herpesviral keratitis and keratoconjunctivitis

Interventions

Intervention 1: Conventional treatment for Non- necrotizing herpetic stromal keratitis including (oral acyclovir 400 mg 5 times a day for 10 days and topical prednisolone acetate 1% eye drop every 2
Treatment - Drugs
Conventional treatment for Non- necrotizing herpetic stromal keratitis including (oral acyclovir 400 mg 5 times a day for 10 days and topical prednisolone acetate 1% eye drop every 2 hours with tape
In another group,beside conventional treatment with oral acyclovir(400mg, 5 times a day for 10 days) and topical prednisolone acetate 1% eye drop every 2 hours with tapering, topical tacrolimus eye dr

Sponsors

Guilan University of Medical Sciences, Pro-Vice -Chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Cases with non-necrotizing herpetic stromal keratitis that are in active phase of disease. Exclusion criteria: Cases with necrotizing stromal keratitis or history of corneal graft, History of intraocular operation and trauma, Pregnant and breast feeding women will exclude for this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in corneal opacity and edema. Timepoint: 3 days, one week, two weeks, three weeks and four weeks after treatment. Method of measurement: clinical exam and scoring.

Secondary

MeasureTime frame
Change in corneal vascularization. Timepoint: 3days,one week,two weeks,three weeks and four weeks after treatment. Method of measurement: clinical exam and scoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mitra Akbari

Guilan University of Medical Sciences

mitra.akbari@gmail.com+98 13 3323 6886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026